Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients
Related Posts
Gottlieb M, Yu H, Chen J, Spatz ES, Gentile NL, Geyer RE, Santangelo M, Malicki C, Gatling K, O'Laughlin KN, Stephens KA, Elmore JG, Wisk[...]
Waqas M, Ahmed M, Ibrahim M, Nasir M, Afridi MK, Fonarow GC, Waqas SA. Efficacy and Safety of Direct Oral Anticoagulants for Extended Treatment of[...]
Natterson-Horowitz B, Wright K, Van Steenkiste G, Decloedt A, Gagnon AL, Cai X, Mazmanian A. Arrhythmias across the tree of life: comparative insights for human[...]